Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.220
+0.030 (2.52%)
Nov 21, 2024, 11:04 AM EST - Market open
Biodesix Revenue
Biodesix had revenue of $18.15M in the quarter ending September 30, 2024, with 34.54% growth. This brings the company's revenue in the last twelve months to $65.56M, up 48.92% year-over-year. In the year 2023, Biodesix had annual revenue of $49.09M with 28.46% growth.
Revenue (ttm)
$65.56M
Revenue Growth
+48.92%
P/S Ratio
2.10
Revenue / Employee
$302,129
Employees
217
Market Cap
177.47M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accuray | 444.20M |
Heron Therapeutics | 137.74M |
BrainsWay | 38.63M |
scPharmaceuticals | 30.28M |
Caribou Biosciences | 11.48M |
Verastem | 10.00M |
BDSX News
- 19 days ago - Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewsWire
- 23 days ago - Biodesix to Participate in Three Investor Conferences in November - GlobeNewsWire
- 4 weeks ago - Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire
- 6 weeks ago - Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study - Business Wire
- 2 months ago - Biodesix to Present at Two Investor Conferences in September - Business Wire
- 3 months ago - Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Biodesix Announces Second Quarter 2024 Results and Highlights - Business Wire